Mastocitosis sistémica como causa de síncope

Nora, 2006, Indolent systemic mastocytosis as the cause of a long history of unexplained hypotensive episodes, South Med J, 99, 876, 10.1097/01.smj.0000215757.93215.bc Barbie, 2006, Systemic mastocytosis: current classification and novel therapeutic options, Clinical advances in hematology and oncology, 4, 768 Metcalfe, 2005, Mastocytosis, Novartis Found Symp, 271, 232, 10.1002/9780470033449.ch19 Fábrega, 2006 Sperr, 2002, Serum tryptase in patients with mastocytosis: correlation with mast cell burden and implication for defining the category of disease, Int Arch Allergy Inmunol, 128, 344 Florian, 2002, Indolent systemic mastocytosis with elevated serum tryptase, absence of skin lesions, and recurrent severe anaphylactoid episodes, Int Arch Allergy Inmunol, 128, 136 Escribano, 2002, Mastocytosis: current concepts in diagnosis and treatment, Ann Hematol, 81, 677, 10.1007/s00277-002-0575-z Meléndez, 2004, Mastocitosis sistémica con compromiso óseo polióstico, Revista colombiana de Cancerología, 8, 47 Valen, 2005, Mastocytosis: pathology, genetics, and current options for therapy, Leuk Lymphoma, 46, 35, 10.1080/10428190400010775 Mol Diagn, 2006, Molecular diagnosis of mast cell disorders: a paper from the 2005, William Beaumont Hospital Symposium on Molecular Pathology, 8, 412 Wintrobe's clinical hematology. 11th ed. November 1, 2003.